Souhaitez-vous accéder aux communiqués récents ?

TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced a number of management appointments, including Raymond Yip...

NEWTON, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid...

Nashville, Tenn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Today, Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic conditions,...

Expect decision regarding the advancement of an Aβ oligomer-targeted Enhanced Brain DeliveryTM product candidate in early 2026Expect to report topline results for ALTITUDE-AD, a Phase 2 study to...

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Human Risk Management: Hoxhunt" report has been added to ResearchAndMarkets.com's offering.This report demonstrates how Hoxhunt's innovative HRM...

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "CMI Level 3 Award in Principles of Management and Leadership (December 17, 2025)" training has been added to ResearchAndMarkets.com's offering. In...

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "CMI Level 3 Certificate in Principles of Management and Leadership (December 17, 2025)" training has been added to ResearchAndMarkets.com's offering. ...

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "CMI Level 3 Diploma in Principles of Management and Leadership (December 17, 2025)" training has been added to ResearchAndMarkets.com's offering. ...

NEWTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics...

Atana's Signature Training and Analytics Approach Turns Workplace Training into Actionable Outcomes